Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.1002/jcb.26293

Título: CDK9: a key player in cancer and other diseases
Fecha de publicación: 19-jul-2017
Editorial: Wiley
Cita bibliográfica: Journal of Cellular Biochemistry, 2018, Vol. 119, N. 2, pp. 1273-1284
ISSN: Print: 0730-2312
Electronic: 1097-4644
Palabras clave: Cancer pathway
CDK9
Cyclin
Drug targeting
Kinase
Transcription regulation
Viral replication
Resumen: Cyclin-Dependent Kinase 9 (CDK9) is part of a functional diverse group of enzymes responsible for cell cycle control and progression. It associates mainly with Cyclin T1 and forms the Positive Transcription Elongation Factor b (p-TEFb) complex responsible for regulation of transcription elongation and mRNA maturation. Recent studies have highlighted the importance of CDK9 in many relevant pathologic processes, like cancer, cardiovascular diseases, and viral replication. Herein we provide an overview of the different pathways in which CDK9 is directly and indirectly involved.
Autor/es principal/es: Franco, Lia Carolina
Morales, Fátima
Boffo, Silvia
Giordano, Antonio
Versión del editor: https://onlinelibrary.wiley.com/doi/10.1002/jcb.26293
URI: http://hdl.handle.net/10201/144343
DOI: https://doi.org/10.1002/jcb.26293
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 12
Derechos: info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Descripción: © 2017 Wiley Periodicals, Inc. This document is the Submitted version of a Published Work that appeared in final form in Journal of Cellular Biochemistry. To access the final edited and published work see https://doi.org/10.1002/jcb.26293
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
CDK9 JCB new format_50refs.pdf287,7 kBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons